Top Markets
Coin of the day
Eastgate Biotech Corp. Eastgate Biotech Corp.

Eastgate Biotech Corp.

ETBI
Rank in Stocks #34128
EastGate Biotech Corp. is a pharmaceutical company specializing in the... EastGate Biotech Corp. is a pharmaceutical company specializing in the production and distribution of nutraceuticals. These products are rooted in natural therapies and designed for natural absorption within the body. The firm employs cutting-edge nanotechnologies to provide healthier options compared to conventional pharmaceuticals, which often lead to detrimental side effects and unforeseen issues for individuals seeking to achieve and maintain good health. Among its diverse product line are E-Drops NANO, Essential D, GluCora, VCleanzz, Cleanezze, and Warts X. EastGate Biotech's development process involves integrating product components into various nano-sized delivery systems. These systems include oil droplets (nanoemulsions), polymeric particles (nanoparticles), and complex combinations of polymers, lipids, and surfactants (such as hybrid nanoparticles, nanocapsules, and mixed micelles). The company has operational bases in prominent cities including New York, London SF, Cockfosters BP, Los Angeles, Chicago, and Las Vegas.
Share Price
$0.003
Last synced: 2026-08-13
Market Cap
$6.17M
Change (1 day)
0.00%
Change (1 year)
-25.00%
Country
CA
Trade Eastgate Biotech Corp. (ETBI)

Category

Earnings for Eastgate Biotech Corp. (ETBI)
Earnings in 2026 TTM: 0
According to Eastgate Biotech Corp. latest financial reports the company's current earnings are 0. In 2026 the company made an earning of 0, equal to its 2026 earnings that were of 0. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.
Earnings history for Eastgate Biotech Corp. from 2026 to 2026
Earnings at the end of each year
Year Earnings Change
Not enough data for the provided dates.
Earnings for similar companies or competitors